Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation-Reference-Cited by-同舟云学术

Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation

Published:2013-07-29 Issue:8 Volume:19 Page:896-906
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Takada Yasutsugu¹,Kaido Toshimi²,Asonuma Katsuhiro³,Sakurai Hiroyuki⁴,Kubo Shoji⁵,Kiuchi Tetsuya⁶,Inomata Yukihiro³,Isaji Shuji⁴,Tsumura Hayami⁷,Teramukai Satoshi⁸,Matsubara Yoshihiro⁷,Sakabayashi Satomi⁷,Uemoto Shinji²

Affiliation:

1. Department of Hepatopancreatobiliary and Transplant Surgery; Ehime University; Toon Japan

2. Department of Surgery; Kyoto University; Kyoto Japan

3. Department of Transplantation and Pediatric Surgery; Kumamoto University; Kumamoto Japan

4. Department of Hepatopancreatobiliary and Transplant Surgery; Mie University; Tsu Japan

5. Department of Hepatopancreatobiliary Surgery; Osaka City University; Osaka Japan

6. Department of Transplant Surgery; Nagoya University; Nagoya Japan

7. Translational Research Informatics Center; Foundation for Biomedical Research and Innovation; Kobe Japan

8. Translational Research Center; Kyoto University Hospital; Kyoto Japan

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.23679/fullpdf

Reference37 articles.

1. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes;Prieto;Hepatology,1999

2. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients;Gane;Liver Transpl,2003

3. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV− recipients;Velidedeoglu;Transplantation,2004

4. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

5. Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database;Irish;Am J Transplant,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024

2. Combination Therapy of Low-dose Steroids, Tacrolimus and Mycophenolate Mofetil in Primary Membranous Nephropathy: A Single-center Retrospective Cohort Study;Integrative Medicine in Nephrology and Andrology;2023-04-29

3. Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation;Frontiers in Pharmacology;2022-10-13

4. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

5. Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials;Clinics;2021